US Tech 100

19,641.60

0.83%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

QGEN

Qiagen NV (QGEN)

Qiagen NV

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:QGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next >>

Date	Time	Source	Headline	Symbol	Company
01/27/2022	12:29PM	Business Wire	Human Rights Campaign und Bloomberg würdigen QIAGENs Engagement im Bereich LGBTQ+- und Geschlechtergleichstellung	NYSE:QGEN	Qiagen NV
01/26/2022	6:08AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NYSE:QGEN	Qiagen NV
01/25/2022	1:30AM	Business Wire	QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance	NYSE:QGEN	Qiagen NV
01/25/2022	1:30AM	Business Wire	QIAGEN rüstet im Auftrag von US-Bundesbehörde lokale Gesundheitslabore mit digitalem PCR-System QIAcuity für die COVID-19 Überwachung aus	NYSE:QGEN	Qiagen NV
01/19/2022	8:20AM	Business Wire	QIAGEN N.V. to release results for Q4 2021 and Full-Year of 2021	NYSE:QGEN	Qiagen NV
01/18/2022	4:05PM	Business Wire	QIAGEN führt mit QIAwave umweltfreundliche Produktlinie ein	NYSE:QGEN	Qiagen NV
01/18/2022	4:05PM	Business Wire	QIAGEN Launches QIAwave Portfolio of Environmentally Friendly Products	NYSE:QGEN	Qiagen NV
01/17/2022	3:15AM	TipRanks	DZ BANK AG Upgrades Qiagen (QGEN) to Buy	NYSE:QGEN	Qiagen NV
01/10/2022	10:12AM	Business Wire	QIAGEN erweitert QIAstat-Dx-Menü um weitere syndromische Tests und kündigt Pläne zur Einführung der neuen Version QIAstat-Dx Rise mit höherem Durchsatz an	NYSE:QGEN	Qiagen NV
01/10/2022	10:12AM	Business Wire	QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version	NYSE:QGEN	Qiagen NV
01/07/2022	1:30AM	Business Wire	QIAGEN stärkt das wachsende Anwendungsportfolio seiner digitalen PCR-Plattform QIAcuity mit neuen Kooperationen	NYSE:QGEN	Qiagen NV
01/07/2022	1:30AM	Business Wire	QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations	NYSE:QGEN	Qiagen NV
01/06/2022	4:05PM	Business Wire	QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB	NYSE:QGEN	Qiagen NV
01/06/2022	4:05PM	Business Wire	QIAGEN erweitert sein QuantiFERON-Portfolio im Kampf gegen TB	NYSE:QGEN	Qiagen NV
12/21/2021	4:28AM	TipRanks	Kepler Capital Downgrades Qiagen (QGEN) to Hold	NYSE:QGEN	Qiagen NV
12/21/2021	4:15AM	TipRanks	Qiagen (QGEN) was Downgraded to a Hold Rating at Kepler Capital	NYSE:QGEN	Qiagen NV
12/09/2021	9:30AM	PR Newswire (US)	Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)	NYSE:QGEN	Qiagen NV
12/09/2021	1:30AM	Business Wire	QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)	NYSE:QGEN	Qiagen NV
12/09/2021	1:30AM	Business Wire	QIAGEN und Denovo Biopharma entwickeln Begleitdiagnostikum für die Behandlung diffuser großzelliger B-Zell-Lymphome (DLBCL)	NYSE:QGEN	Qiagen NV
12/02/2021	1:10AM	Business Wire	QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19	NYSE:QGEN	Qiagen NV
12/02/2021	1:10AM	Business Wire	QIAGEN lanciert CE-gekennzeichnete Version des QuantiFERON® SARS-CoV-2 Tests zur Bestimmung der T-Zell-Reaktion auf COVID-19	NYSE:QGEN	Qiagen NV
12/01/2021	12:15PM	TipRanks	Qiagen (QGEN) Receives a Hold from Goldman Sachs	NYSE:QGEN	Qiagen NV
11/29/2021	4:36AM	TipRanks	Qiagen Reaffirms Effectiveness of PCR Tests on Omnicron Variant	NYSE:QGEN	Qiagen NV
11/29/2021	1:10AM	Business Wire	QIAGEN und DiaSorin erweitern Zugang zu Tests auf latente TB in den USA mit FDA-Zulassung des QuantiFERON®-TB Gold Plus Tests für LIAISON®-XS-Plattformen	NYSE:QGEN	Qiagen NV
11/29/2021	1:10AM	Business Wire	QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS	NYSE:QGEN	Qiagen NV
11/26/2021	11:18AM	Business Wire	QIAGEN bestätigt Wirksamkeit seiner PCR-Tests auf SARS-CoV-2 angesichts der neuen Coronavirus-Variante B.1.1.529	NYSE:QGEN	Qiagen NV
11/26/2021	9:18AM	Business Wire	QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529	NYSE:QGEN	Qiagen NV
11/08/2021	4:05PM	Business Wire	QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050	NYSE:QGEN	Qiagen NV
11/08/2021	4:05PM	Business Wire	QIAGEN verpflichtet sich zur Verringerung der Kohlenstoffemissionen und setzt sich das wissenschaftlich fundierte Ziel, bis 2050 „net zero“ Emissionen zu erreichen	NYSE:QGEN	Qiagen NV
11/08/2021	6:02AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NYSE:QGEN	Qiagen NV